Successful Protection against Tularemia in C57BL/6 Mice Is Correlated with Expansion of Francisella tularensis-Specific Effector T Cells

Lipids Derived from Virulent Francisella tularensis Broadly Inhibit Pulmonary Inflammation via Toll-Like Receptor 2 and Peroxisome Proliferator-Activated Receptor α

(2013) Deborah D. Crane et al.   Clinical and Vaccine Immunology

Differentiation of Antigen-Specific T Cells with Limited Functional Capacity during Mycobacterium tuberculosis Infection

(2013) Yun Hee Jeong et al.   INFECTION AND IMMUNITY

FeoB-Mediated Uptake of Iron by Francisella tularensis

(2013) Cindy A. Thomas-Charles et al.   INFECTION AND IMMUNITY

B1a Cells Enhance Susceptibility to Infection with Virulent Francisella tularensis via Modulation of NK/NKT Cell Responses

(2013) D. D. Crane et al.   JOURNAL OF IMMUNOLOGY

IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection

(2013) Amanda A. Melillo et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Alternative Activation of Macrophages and Induction of Arginase Are Not Components of Pathogenesis Mediated by Francisella Species

(2013) Amanda J. Griffin et al.   PLoS One

Mechanisms of Francisella tularensis Intracellular Pathogenesis

(2013) J. Celli et al.   Cold Spring Harbor Perspectives in Medicine

Purine Biosynthesis Mutants (purA and purB) of Serotype 4b Listeria monocytogenes Are Severely Attenuated for Systemic Infection in Intragastrically Inoculated A/J Mice

(2012) Nancy G. Faith et al.   Foodborne Pathogens and Disease

Generation of a Convalescent Model of Virulent Francisella tularensis Infection for Assessment of Host Requirements for Survival of Tularemia

(2012) Deborah D. Crane et al.   PLoS One

BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: Association of protection with post-vaccination and post-challenge immune responses

(2012) Susan Twine et al.   VACCINE

Immunity to Francisella

(2011) Siobhán C. Cowley et al.   Frontiers in Microbiology

Francisella tularensis  pyrF Mutants Show that Replication in Nonmacrophages Is Sufficient for Pathogenesis In Vivo

(2010) J. Horzempa et al.   INFECTION AND IMMUNITY

Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs

(2010) Rebecca V. Anderson et al.   VACCINE

The Presence of CD14 Overcomes Evasion of Innate Immune Responses by Virulent Francisella tularensis in Human Dendritic Cells In Vitro and Pulmonary Cells In Vivo

(2009) J. C. Chase et al.   INFECTION AND IMMUNITY

Identification of Genes Contributing to the Virulence of Francisella tularensis SCHU S4 in a Mouse Intradermal Infection Model

(2009) Konstantin Kadzhaev et al.   PLoS One

Direct and Indirect Impairment of Human Dendritic Cell Function by Virulent Francisella tularensis Schu S4

(2008) J. C. Chase et al.   INFECTION AND IMMUNITY

The Membrane Form of Tumor Necrosis Factor Is Sufficient to Mediate Partial Innate Immunity toFrancisella tularensisLive Vaccine Strain

(2008) Siobhán C. Cowley et al.   JOURNAL OF INFECTIOUS DISEASES

A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge

(2008) Roger D. Pechous et al.   PLoS One

An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain

(2008) Chandra Shekhar Bakshi et al.   VACCINE